BRPI1006534A2 - sal do composto 1, processo para preparar um sal do composto 1, e processo para preparar um sal misto do composto 1 - Google Patents
sal do composto 1, processo para preparar um sal do composto 1, e processo para preparar um sal misto do composto 1Info
- Publication number
- BRPI1006534A2 BRPI1006534A2 BRPI1006534A BRPI1006534A BRPI1006534A2 BR PI1006534 A2 BRPI1006534 A2 BR PI1006534A2 BR PI1006534 A BRPI1006534 A BR PI1006534A BR PI1006534 A BRPI1006534 A BR PI1006534A BR PI1006534 A2 BRPI1006534 A2 BR PI1006534A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- salt
- preparing
- mixed
- mixed salt
- Prior art date
Links
- 229940125904 compound 1 Drugs 0.000 title 3
- 150000003839 salts Chemical class 0.000 title 3
- 238000004519 manufacturing process Methods 0.000 title 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16280509P | 2009-03-24 | 2009-03-24 | |
| US61/162,805 | 2009-03-24 | ||
| PCT/US2010/028490 WO2010111381A2 (en) | 2009-03-24 | 2010-03-24 | Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1006534A2 true BRPI1006534A2 (pt) | 2016-08-02 |
| BRPI1006534B1 BRPI1006534B1 (pt) | 2021-05-25 |
Family
ID=42781851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1006534-2A BRPI1006534B1 (pt) | 2009-03-24 | 2010-03-24 | Sal do composto 1, processo para preparar um sal do composto 1, e processo para preparar um sal misto do composto 1 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8501753B2 (pt) |
| EP (1) | EP2411394B1 (pt) |
| JP (1) | JP5766687B2 (pt) |
| KR (1) | KR101763672B1 (pt) |
| CN (1) | CN102448963B (pt) |
| AU (1) | AU2010230008B2 (pt) |
| BR (1) | BRPI1006534B1 (pt) |
| CA (1) | CA2755950C (pt) |
| EA (1) | EA020931B1 (pt) |
| ES (1) | ES2519568T3 (pt) |
| IL (1) | IL215298A (pt) |
| MX (1) | MX2011009928A (pt) |
| NZ (1) | NZ595590A (pt) |
| PL (1) | PL2411394T3 (pt) |
| RU (1) | RU2489435C2 (pt) |
| SG (1) | SG174517A1 (pt) |
| WO (1) | WO2010111381A2 (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2280973T3 (pl) | 2008-04-23 | 2013-05-31 | Gilead Sciences Inc | Analogi karba-nukleozydowe do leczenia przeciwwirusowego |
| NZ599404A (en) | 2009-09-21 | 2014-02-28 | Gilead Sciences Inc | Processes and intermediates for the preparation of 1’-substituted carba-nucleoside analogs |
| EA025311B1 (ru) | 2010-07-19 | 2016-12-30 | Гайлид Сайэнсиз, Инк. | Способы получения диастереомерно чистых фосфорамидатных пролекарств |
| PT2595980E (pt) | 2010-07-22 | 2014-11-27 | Gilead Sciences Inc | Métodos e compostos para tratar infeções pelo vírus da família paramyxoviridae |
| AR090699A1 (es) * | 2012-04-18 | 2014-12-03 | Biocryst Pharm Inc | Compuestos inhibidores de la actividad de la arn polimerasa viral |
| TWI698444B (zh) | 2014-10-29 | 2020-07-11 | 美商基利科學股份有限公司 | 製備核糖苷的方法 |
| DK3349758T3 (da) | 2015-09-16 | 2022-06-13 | Gilead Sciences Inc | Fremgangsmåder til behandling af arenaviridae-virusinfektioner |
| CN110869028B (zh) | 2017-03-14 | 2023-01-20 | 吉利德科学公司 | 治疗猫冠状病毒感染的方法 |
| EP4219513A1 (en) | 2017-05-01 | 2023-08-02 | Gilead Sciences, Inc. | Crystalline form of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate |
| CN111093627B (zh) | 2017-07-11 | 2024-03-08 | 吉利德科学公司 | 用于治疗病毒感染的包含rna聚合酶抑制剂和环糊精的组合物 |
| KR20220132608A (ko) | 2020-01-27 | 2022-09-30 | 길리애드 사이언시즈, 인코포레이티드 | SARS CoV-2 감염증을 치료하기 위한 방법 |
| TWI785528B (zh) | 2020-03-12 | 2022-12-01 | 美商基利科學股份有限公司 | 1’-氰基核苷之製備方法 |
| JP7482250B2 (ja) | 2020-04-06 | 2024-05-13 | ギリアード サイエンシーズ， インコーポレイテッド | １’－シアノ置換カルバヌクレオシド類似体の吸入製剤 |
| EP4157272B1 (en) | 2020-05-29 | 2025-07-02 | Gilead Sciences, Inc. | Remdesivir for the treatment of viral infections |
| IL299202A (en) | 2020-06-24 | 2023-02-01 | Gilead Sciences Inc | 1'-cyano nucleoside analogs and uses thereof |
| US11926645B2 (en) | 2020-08-27 | 2024-03-12 | Gilead Sciences, Inc. | Compounds and methods for treatment of viral infections |
| KR102580079B1 (ko) * | 2020-10-29 | 2023-09-19 | 한양대학교 산학협력단 | 기생 인덕턴스 감소를 위한 적층형 회로 구조체 |
| GB202110403D0 (en) * | 2021-07-20 | 2021-09-01 | Laevoroc Immunology | Ulodesine Salt |
| KR20240154647A (ko) | 2022-03-02 | 2024-10-25 | 길리애드 사이언시즈, 인코포레이티드 | 바이러스성 감염 치료를 위한 화합물 및 방법 |
| EP4547665A1 (en) | 2022-06-30 | 2025-05-07 | Gilead Sciences, Inc. | Solid forms of a nucleoside analogue and uses thereof |
| US12357577B1 (en) | 2024-02-02 | 2025-07-15 | Gilead Sciences, Inc. | Pharmaceutical formulations and uses thereof |
| GB202218782D0 (en) | 2022-12-13 | 2023-01-25 | Mehrling Thomas | Purine nucleoside phosphorylase inhibitor for metabolic syndrome |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3870732A (en) | 1973-08-21 | 1975-03-11 | Velsicol Chemical Corp | Mixed salts of aluminum |
| US5386031A (en) * | 1993-12-15 | 1995-01-31 | Warner-Lambert Company | Process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4H-pyrrolo[3,]pyrimidin-4-ones |
| WO1998054185A1 (en) * | 1997-05-29 | 1998-12-03 | Novartis Ag | 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-ones |
| US7553839B2 (en) * | 2002-08-21 | 2009-06-30 | Industrial Research Limited | 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
| NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
-
2010
- 2010-03-24 MX MX2011009928A patent/MX2011009928A/es active IP Right Grant
- 2010-03-24 WO PCT/US2010/028490 patent/WO2010111381A2/en not_active Ceased
- 2010-03-24 NZ NZ595590A patent/NZ595590A/xx unknown
- 2010-03-24 JP JP2012502204A patent/JP5766687B2/ja active Active
- 2010-03-24 EP EP10756789.3A patent/EP2411394B1/en active Active
- 2010-03-24 BR BRPI1006534-2A patent/BRPI1006534B1/pt active IP Right Grant
- 2010-03-24 SG SG2011068608A patent/SG174517A1/en unknown
- 2010-03-24 CN CN201080022925.6A patent/CN102448963B/zh active Active
- 2010-03-24 PL PL10756789T patent/PL2411394T3/pl unknown
- 2010-03-24 RU RU2011141212/04A patent/RU2489435C2/ru active
- 2010-03-24 CA CA2755950A patent/CA2755950C/en active Active
- 2010-03-24 US US13/258,497 patent/US8501753B2/en active Active
- 2010-03-24 EA EA201190205A patent/EA020931B1/ru unknown
- 2010-03-24 KR KR1020117024909A patent/KR101763672B1/ko active Active
- 2010-03-24 AU AU2010230008A patent/AU2010230008B2/en active Active
- 2010-03-24 ES ES10756789.3T patent/ES2519568T3/es active Active
-
2011
- 2011-09-22 IL IL215298A patent/IL215298A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010111381A2 (en) | 2010-09-30 |
| NZ595590A (en) | 2013-11-29 |
| IL215298A (en) | 2017-04-30 |
| JP5766687B2 (ja) | 2015-08-19 |
| JP2012521992A (ja) | 2012-09-20 |
| SG174517A1 (en) | 2011-10-28 |
| WO2010111381A3 (en) | 2011-03-31 |
| PL2411394T3 (pl) | 2015-01-30 |
| AU2010230008B2 (en) | 2015-06-04 |
| KR101763672B1 (ko) | 2017-08-01 |
| IL215298A0 (en) | 2011-12-29 |
| KR20120005466A (ko) | 2012-01-16 |
| CN102448963A (zh) | 2012-05-09 |
| EP2411394A4 (en) | 2012-08-15 |
| EP2411394A2 (en) | 2012-02-01 |
| CA2755950C (en) | 2017-04-25 |
| EP2411394B1 (en) | 2014-08-06 |
| CN102448963B (zh) | 2015-06-17 |
| ES2519568T3 (es) | 2014-11-07 |
| EA201190205A1 (ru) | 2012-06-29 |
| MX2011009928A (es) | 2012-03-16 |
| CA2755950A1 (en) | 2010-09-30 |
| BRPI1006534B1 (pt) | 2021-05-25 |
| AU2010230008A1 (en) | 2011-10-06 |
| US8501753B2 (en) | 2013-08-06 |
| HK1170486A1 (en) | 2013-03-01 |
| EA020931B1 (ru) | 2015-02-27 |
| RU2011141212A (ru) | 2013-04-27 |
| RU2489435C2 (ru) | 2013-08-10 |
| US20120165526A1 (en) | 2012-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0918038A2 (pt) | Processos para preparar um composto e um sal, e, composto | |
| BRPI0910910A2 (pt) | processo para preparar um composto | |
| BRPI0910911A2 (pt) | processo para preparar um composto | |
| BRPI0911254A2 (pt) | processo para a preparação de um composto | |
| BRPI0919018A2 (pt) | sal farmaceuticamente aceitável, uso de sal, e, processo para a preparação de sal | |
| BRPI0911041A2 (pt) | processo para a preparação de sal de polímero de amina | |
| BRPI1012018A2 (pt) | processo para preparar um composto | |
| BR112013008008A2 (pt) | composto, composição farmacêutica e processo para preparar um composto | |
| BRPI0908252A2 (pt) | Processo para preparar um composto, e, uso de um composto | |
| BRPI0923007A2 (pt) | Sal de piperazina e um processo para preparação do mesmo | |
| BR112013011574A2 (pt) | composição de fertilizante de liberação controlada, e, processo para produzir um fertilizante de liberação controlada | |
| BRPI0820851A2 (pt) | Processo para preparar microcápsulas | |
| BRPI1010933A2 (pt) | processo para a preparação de um pó, e, composto | |
| BRPI0922836A2 (pt) | processo para a preparação de um sal de succinato monovalente | |
| BRPI0914674A2 (pt) | processo para preparação de um pó | |
| BR112012029226A2 (pt) | processo para a preparação de um composto quiral, composto quiral cristalino, sal de hcl do composto quiral cristalino, composto quiral e uso do composto | |
| BRPI0911897A2 (pt) | Processo para a preparação de compostos, e, composto | |
| BR112012014490A2 (pt) | processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses | |
| BRPI1011888A2 (pt) | processo para preparar um composto, e, composição. | |
| BR112014003111A2 (pt) | processo para preparar um composto de 1h-pirazol-5- carbonilcloreto n-substituído e processo para preparar um composto de sulfimina | |
| BRPI1014691A2 (pt) | Composto, e, processo para a preparação de um composto. | |
| BRPI0921420A2 (pt) | processo para preparar compostos | |
| BR112012016201A2 (pt) | ''composto, processo para a preparação de um composto, composição farmacêutica e uso de um composto'' | |
| BRPI1016109A2 (pt) | "composto, composição farmacêutica, e, processo para preparar um composto" | |
| BR112012029225A2 (pt) | processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 487/04 , C07D 403/04 Ipc: C07D 487/04 (2006.01), C07D 403/04 (2006.01), A61K |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/03/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |